Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment
Künye
Dayangaç, M. (2018). Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment. Joint International Congress of ILTS, ELITA and LICAGE içinde (213-213. ss.). Lisbon, Portugal, 23-26 May 2018.Özet
…
WoS Q Kategorisi
Q1Kaynak
Joint International Congress of ILTS, ELITA and LICAGECilt
102Sayı
Supplement: 5Koleksiyonlar
- Bildiri Koleksiyonu [515]
- WoS İndeksli Yayınlar Koleksiyonu [6432]